BMC Cancer
- SU Y, Liang Y, Zhong D, Yan H, et al
Construction and validation of a novel liver function-tumor
burden-inflammation-nutrition (LTIN) score for HCC patients underwent
hepatectomy.
BMC Cancer. 2025;25:504.
- SONG S, Zhang G, Yao Z, Chen R, et al
Deep learning based on intratumoral heterogeneity predicts histopathologic grade
of hepatocellular carcinoma.
BMC Cancer. 2025;25:497.
- WANG Y, Yang Z, Li Z, Huang L, et al
Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in
colorectal cancer.
BMC Cancer. 2025;25:480.
- TANG H, Chai C, Miao X, Su Y, et al
Establishment and characterization of CHC-X1: the third human combined
hepatocellular-cholangiocarcinoma cell line.
BMC Cancer. 2025;25:472.
BMC Gastroenterol
- ZHANG L, Bai L
Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced
MRI for colorectal liver metastases: a case-control study.
BMC Gastroenterol. 2025;25:188.
- YU C, Chen L, Hu W, Lei X, et al
The role of the advanced lung cancer inflammation index (ALI) in the risk of
liver fibrosis and mortality among US adult MAFLD patients: a cross-sectional
study of NHANES 1999-2018.
BMC Gastroenterol. 2025;25:190.
- ZHANG W, Kang N, Wang Y, Zhang F, et al
Endoscopic treatment for gastroesophageal varices in patients with cirrhosis: a
survey comparing between developed and developing countries.
BMC Gastroenterol. 2025;25:176.
Dig Dis Sci
- PIETRI O, Chicaud M, Andreani T, Chretien Y, et al
Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major
Information with Therapeutic Implication in One Patient Out of Seven.
Dig Dis Sci. 2025;70:1178-1189.
- ZHANG J, Yang Z, Liu X, Yang X, et al
New Insights into the Pathogenesis of Alcoholic Liver Disease Based on Global
Research.
Dig Dis Sci. 2025;70:903-918.
- CHIEN SC, Chiu HC, Chiu YC, Wang RH, et al
Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic
Dysfunction-Associated Fatty Liver Disease (MASLD).
Dig Dis Sci. 2025;70:1190-1200.
- JAGDISH B, Murone J, Venkat D
Implementation of Alcohol Use Disorder Training Curriculum Improves Perceived
Confidence in Treating Alcohol-Related Liver Disorder Amongst Gastroenterology
Fellows.
Dig Dis Sci. 2025;70:1000-1007.
Eur Radiol
- CANNELLA R, Agnello F, Porrello G, Spinello AU, et al
Performance of ultrasound-guided attenuation parameter and 2D shear wave
elastography in patients with metabolic dysfunction-associated steatotic liver
disease.
Eur Radiol. 2025;35:2339-2350.
- REITHMEIER B, Laun FB, Fuhres T, Uder M, et al
Relevance of lesion size in navigator-triggered and free-breathing
diffusion-weighted liver MRI.
Eur Radiol. 2025;35:2106-2115.
- ZHANG Y, Huang C, Meng F, Hu X, et al
Non-invasive assessment of esophageal and fundic varices in patients with primary
biliary cholangitis.
Eur Radiol. 2025;35:2330-2338.
Hepatology
- GE J, Fontil V, Ackerman S, Pletcher MJ, et al
Clinical decision support and electronic interventions to improve care quality in
chronic liver diseases and cirrhosis.
Hepatology. 2023 Aug 23. doi: 10.1097/HEP.0000000000000583.
- ZANUSO V, Rimassa L, Braconi C
The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy.
Hepatology. 2025;81:1365-1386.
- STALLER DW, Panigrahi SS, Jayasinghe YP, Dong Y, et al
A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and
metabolic diseases.
Hepatology. 2025;81:1288-1303.
- HLADY RA, Zhao X, El Khoury LY, Wagner RT, et al
Epigenetic heterogeneity hotspots in human liver disease progression.
Hepatology. 2025;81:1197-1210.
- LEFERE S, Mosca A, Hudert C, Dupont E, et al
Development and validation of pFIB scores for exclusion of significant liver
fibrosis in pediatric MASLD.
Hepatology. 2025;81:1276-1287.
- OJHA U, Kim S, Rhee CY, You J, et al
Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to
prevent liver fibrosis.
Hepatology. 2025;81:1228-1243.
- WANG M, Chiou SH, Ganger D, Ruck J, et al
Liver transplantation provides survival benefit at all levels of frailty: From
the Multicenter Functional Assessment in Liver Transplantation Study.
Hepatology. 2024 Jul 24. doi: 10.1097/HEP.0000000000001030.
- NOBEL YR, Boike JR, Mazumder NR, Thornburg B, et al
Predictors of long-term clinical outcomes after TIPS: An ALTA group study.
Hepatology. 2025;81:1244-1255.
Int J Cancer
- PATEL DP, Loffredo CA, Pupacdi B, Rabibhadana S, et al
Associations of chronic liver disease and liver cancer with glyphosate and its
metabolites in Thailand.
Int J Cancer. 2025;156:1885-1897.
J Comput Assist Tomogr
- SETIAWAN H, Ria F, Abadi E, Marin D, et al
Development and Clinical Evaluation of a Contrast Optimizer for Contrast-Enhanced
CT Imaging of the Liver.
J Comput Assist Tomogr. 2025;49:239-246.
J Gastroenterol
- HANAMATSU H, Suda G, Ohara M, Ogawa K, et al
Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis
in patients with MASLD.
J Gastroenterol. 2025;60:456-468.
J Hepatol
- RAN S, Zhang J, Tian F, Qian ZM, et al
Association of metabolic signatures of air pollution with MASLD: Observational
and Mendelian randomization study.
J Hepatol. 2025;82:560-570.
- YANG X, Deng B, Zhao W, Guo Y, et al
FABP5(+) lipid-loaded macrophages process tumour-derived unsaturated fatty acid
signal to suppress T-cell antitumour immunity.
J Hepatol. 2025;82:676-689.
- BURKE L, Bernal W, Pirani T, Agarwal B, et al
Plasma exchange does not improve overall survival in patients with acute liver
failure in a real-world cohort.
J Hepatol. 2025;82:615-621.
- VILAR-GOMEZ E, Gawrieh S, Vuppalanchi R, Kettler C, et al
PNPLA3 rs738409, environmental factors and liver-related mortality in the US
population.
J Hepatol. 2025;82:571-581.
- MEIJNIKMAN AS, Fondevila MF, Arrese M, Kisseleva T, et al
Towards more consistent models and consensual terminology in preclinical research
for steatotic liver disease.
J Hepatol. 2025;82:760-766.
- ARAB JP, Diaz LA, Rehm J, Im G, et al
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position
statement by an expert panel on alcohol-related liver disease.
J Hepatol. 2025;82:744-756.
PLoS Genet
- CHEN L, Yang H, Wang J, Zhang H, et al
MEOX1-mediated transcriptional regulation of circABHD3 exacerbates hepatic
fibrosis through promoting m6A/YTHDF2-dependent YPEL3 mRNA decay to activate
beta-catenin signaling.
PLoS Genet. 2025;21:e1011622.
PLoS One
- ADEYEMI O, Osuntoki A, Magbagbeola O, Abdel Hamid MM, et al
Evidence for infectious merozoites of Plasmodium falciparum from natural isolates
of cultured hepatoma cells infected with sporozoites.
PLoS One. 2025;20:e0319901.
- CHEN K, Yang M, Li G, Wang W, et al
Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH
etiologies of hepatocellular carcinoma: A systematic review and meta-analysis.
PLoS One. 2025;20:e0317730.
- LIN L, Xie Y, Lin Z, Lin C, et al
Machine learning for predicting metabolic-associated fatty liver disease
including NHHR: a cross-sectional NHANES study.
PLoS One. 2025;20:e0319851.
Radiology
- DELL T, Mesropyan N, Layer Y, Tischler V, et al
Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical
Validation Study.
Radiology. 2025;314:e241677.
Transplant Proc
- WANG H, Qu W, Liu Y, Zhang L, et al
Recurrence of Myopathy After Liver Transplantation for Patients With End-Stage
GSD Type IIIa.
Transplant Proc. 2025 Mar 3:S0041-1345(25)00093.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016